000 | 01862 a2200481 4500 | ||
---|---|---|---|
005 | 20250516201010.0 | ||
264 | 0 | _c20141023 | |
008 | 201410s 0 0 eng d | ||
022 | _a1558-075X | ||
024 | 7 |
_a10.1053/j.semperi.2013.11.004 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aNair, Jayasree | |
245 | 0 | 0 |
_aUpdate on PPHN: mechanisms and treatment. _h[electronic resource] |
260 |
_bSeminars in perinatology _cMar 2014 |
||
300 |
_a78-91 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdministration, Inhalation |
650 | 0 | 4 |
_aAlprostadil _xtherapeutic use |
650 | 0 | 4 |
_aAsphyxia Neonatorum _xcomplications |
650 | 0 | 4 |
_aEndothelium-Dependent Relaxing Factors _xtherapeutic use |
650 | 0 | 4 |
_aEpoprostenol _xtherapeutic use |
650 | 0 | 4 |
_aExtracorporeal Membrane Oxygenation _xmethods |
650 | 0 | 4 |
_aHernia, Diaphragmatic _xcomplications |
650 | 0 | 4 | _aHernias, Diaphragmatic, Congenital |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInfant, Newborn |
650 | 0 | 4 |
_aMeconium Aspiration Syndrome _xcomplications |
650 | 0 | 4 |
_aNitric Oxide _xtherapeutic use |
650 | 0 | 4 |
_aOxygen Inhalation Therapy _xmethods |
650 | 0 | 4 |
_aPersistent Fetal Circulation Syndrome _xetiology |
650 | 0 | 4 |
_aPiperazines _xtherapeutic use |
650 | 0 | 4 |
_aPulmonary Surfactants _xtherapeutic use |
650 | 0 | 4 |
_aPurines _xtherapeutic use |
650 | 0 | 4 |
_aRespiration, Artificial _xmethods |
650 | 0 | 4 |
_aRespiratory Distress Syndrome, Newborn _xcomplications |
650 | 0 | 4 | _aSildenafil Citrate |
650 | 0 | 4 |
_aSulfones _xtherapeutic use |
650 | 0 | 4 |
_aVascular Resistance _xphysiology |
650 | 0 | 4 |
_aVasodilator Agents _xtherapeutic use |
700 | 1 | _aLakshminrusimha, Satyan | |
773 | 0 |
_tSeminars in perinatology _gvol. 38 _gno. 2 _gp. 78-91 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1053/j.semperi.2013.11.004 _zAvailable from publisher's website |
999 |
_c23596328 _d23596328 |